World News: 12:00 GMT Monday 5th February 2018. [Merus N.V. via Thomson Reuters ONE via SPi World News]
UTRECHT The Netherlands Feb 05 2018 GLOBE NEWSWIRE -- Merus NV NasdaqMRUS a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics Biclonics today announced that the Companys management will p...
Thomson Reuters: 12:00 GMT Monday 5th February 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.